Merck & Co Inc <MRK.N> reported higher-than-expected second-quarter profit on Tuesday, powered by strong demand for its cancer immunotherapy Keytruda and vaccines, sending its shares up 3% in early trading.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,